P42345 (MTOR_HUMAN) Homo sapiens (Human)
Serine/threonine-protein kinase mTOR UniProtKBInterProSTRINGInteractive Modelling
Available Structures
54 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| cryo-EM structure of LST2 TOS peptide bound to human mTOR complex 1 |
Heteromer Q8N122; Q9BVC4; Q9HCC9; | 100.0 | 2×IHP; | |||
| cryo-EM structure of DEPTOR bound to human mTOR complex 1, overall refinement |
Heteromer Q8N122; Q8TB45; Q9BVC4; | 97.44 | 2×IHP; | |||
| cryo-EM structure of human LST2 bound to human mTOR complex 1 |
Heteromer Q8N122; Q9BVC4; Q9HCC9; | 100.0 | 2×IHP; | |||
| cryo-EM structure of DEPTOR bound to human mTOR complex 1, focussed on one protomer |
Heteromer Q8N122; Q8TB45; Q9BVC4; | 97.44 | 1×IHP; | |||
| cryo-EM structure of DEPTOR bound to human mTOR complex 1, DEPt-bound subset local refinement |
Heteromer Q8N122; Q8TB45; Q9BVC4; | 97.44 | 1×IHP; | |||
| RMC-5552 in complex with mTORC1 and FKBP12 |
Heteromer P62942; Q8N122; Q9BVC4; | 100.0 | 1×XZ9; 1×XYU; | |||
| cryo-EM structure of human mTOR complex 2, overall refinement |
Heteromer Q6R327; Q9BPZ7; Q9BVC4; | 100.0 | 4×AGS; 2×IHP; 2×ZN; 2×ACE; | |||
| The apo structure of human mTORC2 complex |
Heteromer Q6R327; Q9BPZ7; Q9BVC4; | 100.0 | ||||
| 4.9 Angstrom Cryo-EM structure of human mTOR complex 2 |
Heteromer Q6R327; Q9BVC4; | 100.0 | ||||
| cryo-EM structure of DEPTOR bound to human mTOR complex 2, focussed on one protomer |
Heteromer Q6R327; Q8TB45; Q9BPZ7; Q9BVC4; | 100.0 | 1×IHP; 1×ZN; 1×ACE; | |||
| mTORC1 structure refined to 3.0 angstroms |
Heteromer Q13541; Q8N122; Q9BVC4; | 97.29 | 2×ATP; 4×MG; | |||
| cryo-EM structure of DEPTOR bound to human mTOR complex 2, overall refinement |
Heteromer Q6R327; Q8TB45; Q9BPZ7; Q9BVC4; | 100.0 | 2×IHP; 2×ZN; 2×ACE; | |||
| cryo-EM structure of DEPTOR bound to human mTOR complex 2, DEPt-bound subset local refinement |
Heteromer Q6R327; Q8TB45; Q9BPZ7; Q9BVC4; | 100.0 | 1×IHP; 1×ZN; 1×ACE; | |||
| Cryo-EM structure of the activated RHEB-mTORC1 refined to 3.4 angstrom |
Heteromer Q13541; Q15382; Q8N122; Q9BVC4; | 97.32 | 2×ATP; 6×MG; 2×GTP; | |||
| human DEPTOR in a complex with mutant human mTORC1 A1459P |
Heteromer Q8N122; Q8TB45; Q9BVC4; | 97.44 | ||||
| cryo-EM structure of the mTORC1-TFEB-Rag-Ragulator complex with symmetry expansion |
Heteromer O43504; P19484; Q0VGL1; Q6IAA8; Q7L523; Q8N122; Q9BVC4; Q9HB90; Q9UHA4; Q9Y2Q5; | 100.0 | 1×IHP; 2×GTP; 2×MG; 2×GDP; | |||
| cryo-EM structure of the mTORC1-TFEB-Rag-Ragulator complex |
Heteromer O43504; P19484; Q0VGL1; Q6IAA8; Q7L523; Q8N122; Q9BVC4; Q9HB90; Q9UHA4; Q9Y2Q5; | 100.0 | 2×IHP; 4×GTP; 4×MG; 4×GDP; | |||
| cryo-EM structure of mTORC1 bound to active RagA/C GTPases |
Heteromer Q7L523; Q8N122; Q9BVC4; Q9HB90; | 98.84 | 2×GTP; 2×GDP; | |||
| cryo-EM structure of mTORC1 bound to PRAS40-fused active RagA/C GTPases |
Heteromer Q7L523; Q8N122; Q96B36; Q9BVC4; Q9HB90; | 98.84 | 2×GTP; 2×GDP; | |||
| CryoEM structure of mTORC1 with a paediatric kidney cancer-associated 1455-EWED-1458 duplication in… |
Heteromer Q13541; Q8N122; Q9BVC4; | 100.0 | 1×ANP; 2×MG; | |||
| CryoEM structure of mTORC1 with a paediatric kidney cancer-associated 1455-EWED-1458 duplication in… |
Heteromer Q13541; Q8N122; Q9BVC4; | 100.0 | 2×ANP; 4×MG; | |||
| Cryo-EM structure of mTORC1 |
Heteromer Q8N122; Q9BVC4; | 100.0 | ||||
| CryoEM structure of mTORC1 with a paediatric kidney cancer-associated 1455-EWED-1458 duplication in… |
Heteromer Q13541; Q8N122; | 100.0 | 1×ANP; 2×MG; | |||
| cryo-EM structure of human mTOR complex 2, focused on one half |
Heteromer Q6R327; Q9BPZ7; Q9BVC4; | 100.0 | 2×AGS; 1×IHP; 1×ZN; 1×ACE; | |||
| Crystal structure of mTOR(deltaN)-mLST8-PRAS40(beta-strand) complex |
Heteromer Q96B36; Q9BVC4; | 100.0 | ||||
| structure of mTORdeltaN-mLST8 complex |
Heteromer Q9BVC4; | 100.0 | ||||
| structure of mTORDeltaN-mLST8-ATPgammaS-Mg complex |
Heteromer Q9BVC4; | 100.0 | 1×AGS; 2×MG; | |||
| Crystal structure of mTOR(deltaN)-mLST8-PRAS40(alpha-helix & beta-strand) complex |
Heteromer Q96B36; Q9BVC4; | 100.0 | ||||
| mTORdeltaN-mLST8-pp242 complex |
Heteromer Q9BVC4; | 100.0 | 1×P2X; | |||
| structure of mTORDeltaN-mLST8-Torin2 complex |
Heteromer Q9BVC4; | 100.0 | 1×17G; | |||
| mTOR kinase structure, mechanism and regulation. |
Heteromer Q9BVC4; | 100.0 | 1×ADP; 2×MG; 1×MGF; | |||
| structure of mTORDeltaN-mLST8-PI-103 complex |
Heteromer Q9BVC4; | 100.0 | 1×X6K; | |||
| Architecture of human mTOR Complex 1 - 5.9 Angstrom reconstruction |
Heteromer Q9BVC4; | 100.0 | 2×RAP; | |||
| THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN… |
Heteromer P62942; | 100 | 1×RAP; | |||
| ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |
Heteromer P62942; | 100 | 1×ARD; | |||
| THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN… |
Heteromer P62942; | 100 | 1×RAD; | |||
| THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-(C16)-ETHOXY RAPAMYCIN COMPLEX INTERACTI… |
Heteromer P62942; | 100 | 1×RAD; | |||
| ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |
Heteromer P62942; | 100 | 1×ARD; | |||
| FKBP12-FRB in Complex with Compound 11 |
Heteromer P62942; | 100 | 1×XYU; | |||
| FKBP12-FRB in Complex with Compound 12 |
Heteromer P62942; | 100 | 1×XZ3; | |||
| NMR structure of FKBP12-mTOR FRB domain-rapamycin complex structure determined based on PCS |
Heteromer P62942; | 100 | 2×TB; | |||
| Crystal structure of FKBP-FRB T2098L mutant in complex with rapamycin |
Heteromer P62942; | 98.92 | 1×RAP; 8×ZN; 4×CL; | |||
| Co-crystal structure of the FK506 binding domain of human FKBP25, Rapamycin and the FRB domain of h… |
Heteromer Q00688; | 100 | 1×RAP; | |||
| Structure of the FRB domain of mTOR bound to a substrate recruitment peptide of S6K1 |
Heteromer P23443; | 100 | ||||
| Crystal structure of MBP fused split FKBP-FRB T2098L mutant in complex with rapamycin |
Heteromer P0AEX9; P62942; | 98.91 | 1×GLC; 1×RAP; 1×GOL; | |||
| o-crystal structure of the PPIase domain of FKBP52, Rapamycin and the FRB fragment of mTOR |
Heteromer Q02790; | 100 | 1×RAP; 1×SO4; | |||
| Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR |
Heteromer Q13451; | 100 | 1×RAP; | |||
| Co-crystal structure of FKBP12, compound 7 and the FRB fragment of mTOR |
Heteromer P62942; | 100 | 1×0AN; 4×CA; 1×ACT; | |||
| Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR at low … |
Heteromer Q13451; | 100 | 1×RAP; 11×SO4; | |||
| Crystal structure of mTOR docked into EM map of dimeric ATM kinase | monomer | 100.0 | 1×ADP; 2×MG; 1×MGF; | |||
| The solution structure of the rapamycin-binding domain of mTOR (FRB) | monomer | 99.0 | ||||
| NMR SOLUTION STRUCTURE OF THE FRB DOMAIN OF mTOR | monomer | 100 | ||||
| Crystal structure of FRB-FKBP fusion protein in complex with rapamycin | monomer | 100 | 1×RAP; | |||
| FKBP-RAPAMYCIN BINDING DOMAIN (FRB) OF THE FKBP-RAPAMYCIN ASSOCIATED PROTEIN | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 9f45.1.A | monomer | 0.71 | 1×IHP; | 100.00 | ||